|
TMEM60 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.83884027396653E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.87270207621759E-11 |
| Normal-vs-Stage2 |
1.120660E-03 |
| Normal-vs-Stage3 |
2.344200E-02 |
| Normal-vs-Stage4 |
5.977600E-03 |
| Stage1-vs-Stage2 |
9.084800E-01 |
| Stage1-vs-Stage3 |
4.618000E-02 |
| Stage1-vs-Stage4 |
2.020200E-01 |
| Stage2-vs-Stage3 |
1.042160E-01 |
| Stage2-vs-Stage4 |
3.315800E-01 |
| Stage3-vs-Stage4 |
1.869870E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.79334325167702E-12 |
| Normal-vs-AfricanAmerican |
3.49879999994585E-06 |
| Normal-vs-Asian |
8.493600E-02 |
| Caucasian-vs-AfricanAmerican |
4.899000E-01 |
| Caucasian-vs-Asian |
4.970600E-01 |
| AfricanAmerican-vs-Asian |
4.417000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.30451205393456E-13 |
| Normal-vs-Female |
1.98299999976115E-07 |
| Male-vs-Female |
2.555600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.68680000004018E-06 |
| Normal-vs-Extreme_Weight |
5.21479970316818E-10 |
| Normal-vs-Obese |
1.14699999997914E-06 |
| Normal-vs-Extreme_Obese |
3.897500E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.541600E-01 |
| Normal_Weight-vs-Obese |
6.061000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.718200E-01 |
| Extreme_Weight-vs-Obese |
2.763000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.570600E-01 |
| Obese-vs-Extreme_Obese |
3.692200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.939300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.71227484915926E-13 |
| Normal-vs-Age(61-80Yrs) |
3.06569991614936E-10 |
| Normal-vs-Age(81-100Yrs) |
6.017600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.011200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.435800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.502400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.756000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.194800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.512000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.355600E-04 |
| Normal-VS-KIRP CIMP |
1.645210E-01 |
| Normal-VS-Unclassified PRCC |
2.344300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.25530000000462E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.388300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.363500E-04 |
| Type2 PRCC-VS-KIRP CIMP |
7.615400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.931200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.060200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.95210000000423E-05 |
| Normal-vs-N1 |
1.283620E-03 |
| Normal-vs-N2 |
2.563200E-03 |
| N0-vs-N1 |
8.444600E-01 |
| N0-vs-N2 |
8.290800E-01 |
| N1-vs-N2 |
9.025800E-01 |
|
|
